Parliamentary panel mum on drug patent
A Parliamentary committee has failed to recommend a widley-expected strengthening of the country's drug patent law, a development analysts see helping domestic companies at the cost of
A Parliamentary committee has failed to recommend a widley-expected strengthening of the country's drug patent law, a development analysts see helping domestic companies at the cost of